Commercial insurance reimbursements comprise the majority of many hospitals’ revenue. Moreover, because government programs like Medicare do not cover the costs of providing care, commercial reimbursements can be the difference between losing money, breaking even, or earning a sustainable margin.
Amicus Briefs
The AHA weighs in on a number of issues of importance to hospitals and health systems, as well as the patients they care for, as they come before the court. Below are our most recent friend-of-the-court briefs.
Latest
On March 6, AHA, others filed an amicus brief opposing the Sonafi 340B rebate model.
AHA, others file amicus brief in Fourth Circuit in support of West Virginia contract pharmacy law.
AHA, others file amicus brief opposing Eli Lilly, Bristol Meyers Squibb and Novartis 340B rebate models.
AHA, others file amicus brief supporting HRSA decision to reject 340B rebate model policies.
AHA, others file amicus brief opposing J&J 340B rebate model.
AHA, others file amicus brief in Fourth Circuit in support of Maryland 340B contract pharmacy law.
Amici and their member-hospitals know better than anyone that preventive healthcare services are essential for the early diagnosis and treatment of life-threatening illnesses for millions of Americans. Amici write to offer guidance, from hospitals’ perspectives, on the harmful impact that upholding the Fifth Circuit’s decision would have on the American healthcare system and all who depend on it.
AHA Amicus Brief in 5th Circuit Court Challenges FTC Non-compete Rule.
AHA, others challenge Novartis in court filings to defend Mississippi’s 340B contract pharmacy law .
AHA, others challenge PhRMA in court filings to defend Mississippi’s 340B contract pharmacy law.
AHA amicus brief defending Kansas’ 340B Contract Pharmacy Law in ABBVIE INC., et al., case.
AHA/THA Nurse Staffing Rule Amicus Brief in AHCA v. Becerra litigation.
AHA Amicus Brief in Moyle v. United States Remanded Ninth Circuit EMTALA Case
Amicus Brief: ABBVIE INC., et al., v. Keith M. Ellison, in his official capacity as Attorney General of Minnesota Motion to Dismiss 340B Litigation
Amicus Brief: Motion to Dismiss in Astrazeneca Pharmaceuticals LP v Plaintiff, Attorney General of the State of Minnesota in 340B litigation.
No. 24-10561IN THE UNITED STATES COURT OF APPEALSFOR THE FIFTH CIRCUIT
Amicus Brief: AHA, Electronic Health Record Association In Support of PointClickCare Technologies, Inc, re: information blocking and health information IT.
The American Hospital Association, 340B Health, and the American Society of Health-System Pharmacists (collectively, the “Proposed Amici”) respectfully move this Court for leave to file the attached amicus curiae brief in support of Defendants Attorney General Andrew Bailey, President of the Missouri Board of Pharmacy James L. Gray, Vice President of the Missouri Board of Pharmacy Christian S. Tadrus, and Members of the Missouri Board of Pharmacy Douglas R. Lang, Colby Grove, Anita K. Parran, Tammy Thompson, and Darren Harris’s Motion to Dismiss and Opposition to Plaintiff Novartis Pharmaceuticals Corporation’s Motion for Preliminary Injunction (Exhibit A).
The AHA, joined by five other national hospital associations, filed an amicus brief urging the Supreme Court to correct the Department of Health and Human Services’ misinterpretation of the formula set by Congress to calculate Disproportionate Share Hospital (DSH) payments, which includes a Medicare fraction that counts supplemental security income-eligible Medicare beneficiaries in the numerator and the total Medicare-eligible population in the denominator.